Management Credibility Analysis
Upcoming Catalysts
Verified event feedCompany profile
No description available
- Chief executive
- Not disclosed
- Headquarters
- 1020 KIFER ROAD, SUNNYVALE, CA
- Founded
- Not disclosed
📈 Company Timeline
Intuitive Surgical, Inc. filed Form 10-Q
Intuitive Surgical, Inc. submitted Form 10-Q to the SEC for the period ending Sep 30, 2026.
Intuitive Surgical, Inc. reported Operating or financial results
Intuitive Surgical, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
Intuitive Surgical, Inc. reported A charter or bylaws change
Intuitive Surgical, Inc. filed an 8-K covering a charter or bylaws change, supporting financial statements or exhibits.
Intuitive Surgical, Inc. securities registration filing
Intuitive Surgical, Inc. filed a registration or prospectus document concerning securities.
Intuitive Surgical, Inc. filed Form 10-Q
Intuitive Surgical, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
Capital Structure & Financial Position
Financial strength and liquidity analysisSource: SEC EDGAR company facts (opens in a new tab) Balance sheet dated
Peer Comparison - Health Care
| Company | Price | Market Cap |
|---|---|---|
| LLY - Eli Lilly and Company |
$1,276.13
Yahoo Finance |
$1.20T |
| JNJ - Johnson & Johnson |
$256.74
Yahoo Finance |
$618.71B |
| ABBV - AbbVie Inc. |
$284.80
Yahoo Finance |
$503.28B |
| UNH - UnitedHealth Group Incorporated |
$418.43
Yahoo Finance |
$375.58B |
| MRK - Merck & Co., Inc. |
$148.55
Yahoo Finance |
$366.50B |
📋 Corporate Actions
Recent and upcoming corporate eventsFinancials
Financial statements and key metrics analysis| Quarter | Revenue (USD) | Operating income | Net income | Diluted EPS (USD) | Filed |
|---|---|---|---|---|---|
| Q2 2026 | $2.89B | $971.90M | $818.10M | $2.29 | 10-Q · 21 Jul 2026 |
| Q1 2026 | $2.77B | $855.30M | $821.50M | $2.28 | 10-Q · 22 Apr 2026 |
| Q4 2025 | $2.87B | $864.30M | $794.80M | Unavailable | 10-K · 3 Feb 2026 |
| Q3 2025 | $2.51B | $759.70M | $704.40M | $1.95 | 10-Q · 22 Oct 2025 |
| Q2 2025 | $2.44B | $743.40M | $658.40M | $1.81 | 10-Q · 23 Jul 2025 |
| Q1 2025 | $2.25B | $578.10M | $698.40M | $1.92 | 10-Q · 23 Apr 2025 |
Analyst Consensus
Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 391.00–685.00 Ratings are third-party opinions, not advice.
💰 Upcoming Dividends
Next dividend paymentsGuidance Evolution
💼 Director Transactions
Recent insider activityTop Shareholders
Source: Nasdaq institutional holdings (opens in a new tab) Observed · 16 hours ago